Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
8h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
9h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
11h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
19h agoBuffalo Potash Files Annual Information Form and New Technical Report
20h agoIonik Announces 30-Day Extension of Senior Debt Facility
Opus Genetics, Inc. logo

Opus Genetics, Inc.

About

4.26USD-0.03 -0.70%
Closed • Updated at 22:43 GMT+00:00
Market Cap$346.75M
Volume569.5K
Beta0.40
RSI35.42
Gross Margin99.56%
Health TechnologyPharmaceuticals: Major

Opus Genetics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 13 2026
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
May 7 2026
Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study
May 4 2026
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
Apr 27 2026
Opus Genetics to Participate in Leading Medical Conferences in May 2026
Apr 10 2026
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Community Chat

Ask AI

Try asking
6ix6ixAIEvents